Albion Financial Group’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $30.4K | Hold |
251
| – | – | ﹤0.01% | 270 |
|
|
2025
Q1 | $28K | Hold |
251
| – | – | ﹤0.01% | 282 |
|
|
2024
Q4 | $24.4K | Buy |
251
+160
| +176% | +$15.6K | ﹤0.01% | 317 |
|
|
2024
Q3 | $10.5K | Hold |
91
| – | – | ﹤0.01% | 331 |
|
|
2024
Q2 | $9.69K | Hold |
91
| – | – | ﹤0.01% | 335 |
|
|
2024
Q1 | $8.8K | Hold |
91
| – | – | ﹤0.01% | 326 |
|
|
2023
Q4 | $9.19K | Hold |
91
| – | – | ﹤0.01% | 314 |
|
|
2023
Q3 | $9.27K | Hold |
91
| – | – | ﹤0.01% | 303 |
|
|
2023
Q2 | $9.18K | Hold |
91
| – | – | ﹤0.01% | 313 |
|
|
2023
Q1 | $8.37K | Hold |
91
| – | – | ﹤0.01% | 316 |
|
|
2022
Q4 | $8.26K | Hold |
91
| – | – | ﹤0.01% | 315 |
|
|
2022
Q3 | $7K | Hold |
91
| – | – | ﹤0.01% | 330 |
|
|
2022
Q2 | $8K | Sell |
91
-90
| -50% | -$7.91K | ﹤0.01% | 329 |
|
|
2022
Q1 | $16K | Buy |
181
+90
| +99% | +$7.96K | ﹤0.01% | 335 |
|
|
2021
Q4 | $8K | Hold |
91
| – | – | ﹤0.01% | 420 |
|
|
2021
Q3 | $7K | Sell |
91
-53
| -37% | -$4.08K | ﹤0.01% | 395 |
|
|
2021
Q2 | $13K | Buy |
+144
| New | +$13K | ﹤0.01% | 358 |
|
|
2020
Q4 | $9K | Buy |
+91
| New | +$9K | ﹤0.01% | 358 |
|